Listen Score
LS 23
Global Rank
TOP 10%

ABOUT THIS PODCAST 🔗

Update frequency:
biweekly
Average audio length:
45 minutes
Guest interviews
Has sponsors
Video podcast
English
United Kingdom
215 episodes
since March 6, 2019
episodic

AUDIENCE OF THIS PODCAST 🔗

~59.73% of listeners are from United Kingdom.
🇬🇧
GB
59.73%
🇺🇸
US
15.92%
🇰🇷
KR
9.29%
🇱🇻
LV
6.19%
🇵🇭
PH
2.65%
🇩🇪
DE
2.21%
🇳🇱
NL
1.32%
🇮🇪
IE
0.44%
🇨🇿
CZ
0.44%
🇨🇭
CH
0.44%
🇮🇱
IL
0.44%
🇵🇹
PT
0.44%
🇵🇱
PL
0.44%
Others
0.05%
* Data source: directly measured on Listen Notes. real-time

LATEST EPISODE 🔗

What separates the people who build breakthrough therapies from those who burn out before they get there?  In this episode, Ran Frenkel, Co-Founder and CEO of Polaroid Therapeutics, shares the lessons he's learned across more than two decades in Biotech, from failed ventures and high-pressure clin…

SEARCH PAST EPISODES

Search past episodes of Careers in Discovery.

PREVIOUS EPISODES

In this episode of Careers in Discovery, Marie Wikström Lindholm, Chief Scientific Officer at Silence Therapeutics, shares the leadership lessons she's learned throughout her career in Biotech. From trusting the expertise around her to adapting beyond the habits that once drove her success, Marie r…
Most Biotech careers aren’t built on big breakthroughs; they’re built on tough calls. In this episode, Grahame Mackenzie shares what it really takes to build in Biotech, from scaling tiny teams into clinic-delivering companies to knowing when to kill your own projects. He breaks down the mindset …
In this episode, Andrea Braun-Scherhag, SVP and Global Head of Regulatory Affairs & Safety at Autolus, breaks down what it really takes to bring breakthrough therapies to market, especially when there’s no established playbook. From securing rapid global approvals to navigating entirely new pat…
What does it really take to progress from bench science to leading a Biotech platform as Chief Scientific Officer? In this episode of Careers in Discovery, Daniel Tardiff, CSO at Camp4 Therapeutics, shares a candid look at building and scaling science inside an early‑stage biotech. From his founda…
In this episode of Careers in Discovery, Adrian Gabriel Torres, Chief Scientific Officer at Aptadel Therapeutics, talks about developing RNA aptamer–based cancer therapies and leading scientific strategy in a preclinical biotech start-up. Adrian also shares his journey from academic research into i…
This week on Careers on Discovery, we’re joined by Rachel Abbott, CEO of Pan Cancer T. Rachel shares her journey from academic science into biotech leadership, reflecting on the pivotal moments that shaped her career - from early setbacks at university to working on T‑cell therapies that reached p…
This week on Careers in Discovery, we’re joined by Ignacio Moraga, CSO and co‑founder of TECRegen. Ignacio shares his journey from Madrid to the Pasteur Institute, Stanford and Dundee, and now into biotech entrepreneurship. We talk about his work regenerating the thymus to rejuvenate the immune sy…
This week on Careers in Discovery, we’re joined by Sarah Almond, VP of Translational Biology at NRG Therapeutics. Sarah shares her journey from early lab work to leading translational science on a first in class neurodegeneration programme. We talk about the serendipity that shaped her career, th…
This week on Careers in Discovery, we’re joined by Jonathan Levenson, CSO at FireCyte Therapeutics. Jonathan shares his unconventional journey from early curiosity about biology to a career spanning neuroscience research, Biotech innovation, and scientific leadership. We explore his transition fro…
Disclaimer: The podcast and artwork embedded on this page are from Tom Froggatt, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.